These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 2407374
21. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Paganelli F, Alessi MC, Morange P, Maixent JM, Lévy S, Vague IJ. Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462 [Abstract] [Full Text] [Related]
22. [Experience with primary coronary angioplasty in management of patients suffering from acute myocardial infarction]. Maslov LN, Krylov AL. Angiol Sosud Khir; 2008 Jul; 14(1):131-41. PubMed ID: 19156043 [Abstract] [Full Text] [Related]
23. Usefulness of coronary artery bypass graft surgery or percutaneous transluminal angioplasty after thrombolytic therapy. Dodge HT, Sheehan FH, Mathey DG, Brown BG, Kennedy JW. Circulation; 1985 Dec; 72(6 Pt 2):V39-45. PubMed ID: 2933186 [Abstract] [Full Text] [Related]
24. Primary angioplasty for cardiogenic shock complicating acute myocardial infarction. Calton R, Jaison TM, David T. Indian Heart J; 1999 Dec; 51(1):47-54. PubMed ID: 10327779 [Abstract] [Full Text] [Related]
25. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct]. Sarullo FM, Schicchi R, Schirò M, Americo L, Bonnì G, Faraone N, Di Pasquale P, Castello A, Mauri F. Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123 [Abstract] [Full Text] [Related]
26. Effects of thrombolytic agents on coronary recanalization and patency, cardiac enzyme release, left ventricular function, and mortality in patients with acute myocardial infarction. Verstraete M. J Cardiovasc Pharmacol; 1989 Jan; 14 Suppl 9():S38-48. PubMed ID: 2483231 [Abstract] [Full Text] [Related]
33. [Thrombolytic therapy in acute myocardial infarct. 2. Clinical studies with thrombolytic therapy]. Kothe K. Z Gesamte Inn Med; 1990 May 15; 45(10):269-74. PubMed ID: 2203208 [Abstract] [Full Text] [Related]
34. Thrombolytic therapy in the management of acute myocardial infarction. Kennedy JW. Trans Assoc Life Insur Med Dir Am; 1990 May 15; 73():26-36. PubMed ID: 2191485 [Abstract] [Full Text] [Related]
35. [Thrombolytic agents in myocardial infarction: results of large mortality studies]. Slama MS, Motté G. Rev Prat; 1992 Nov 01; 42(17):2143-9. PubMed ID: 1290036 [Abstract] [Full Text] [Related]
36. Reperfusion therapy for acute myocardial infarction. Which strategy for which patient? Boersma E, Steyerberg EW, Van der Vlugt MJ, Simoons ML. Drugs; 1998 Jul 01; 56(1):31-48. PubMed ID: 9664197 [Abstract] [Full Text] [Related]
37. Comparison of thrombolytic agents: selected hematologic, vascular and clinical events. Marder VJ. Am J Cardiol; 1989 Jul 05; 64(2):2A-7A; discussion 24A-26A. PubMed ID: 2662739 [Abstract] [Full Text] [Related]
39. A review of the long term effects of thrombolytic agents. van Domburg RT, Boersma E, Simoons ML. Drugs; 2000 Aug 05; 60(2):293-305. PubMed ID: 10983734 [Abstract] [Full Text] [Related]
40. Comparative tolerability profiles of thrombolytic agents. A review. Woo KS, White HD. Drug Saf; 1993 Jan 05; 8(1):19-29. PubMed ID: 8471185 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]